First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

528 Reviews

Credit Rating - COPPENHALL PHARMACY LTD

ANALYSIS
Credit Risk Update: SECURED CREDITOR INFORMATION: COPPENHALL PHARMACY LTD, 18 NORTH STREET, COPPENHALL, CREWE, CW1 4NL. The legal status is a Private Limited Company and the current status at the registry of companies is Active. The last filed accounts are dated 31 December 2022. The company was incorporated on 17 May 2019.

The accounts next due date is 30 September 2024. There are 2 mortgages, none satisfied, none part satisfied and 2 unsatisfied.

The above was based on public record information as at 10 February 2025 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 12001132
Date Incorporated: 17 May 2019
Date Latest Accounts: 31 December 2022
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: None
Registered Number: 12001132
Annual Return: Unknown
Registered Office: 18 NORTH STREET, COPPENHALL, CREWE, CW1 4NL
SIC Code and Operations: 47730
SECURED CREDITORS
Number of Mortgages 2
Satisfied Mortgages 0
Part Satisfied Mortgages 0
Unsatisfied Mortgages 2
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

COPPENHALL PHARMACY LTD

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 20 February 2025 Copyright © 2025 First Report Ltd


Recent Searches

Reg No. Reg Name Status
09136821 COPPENHALL TRANSPORT LTD Active - Proposal to Strike off
SC073174 COPPENRATH & WIESE (UK) LIMITED Active
14663619 COPPENS CONSULTING LTD Active
14382499 COPPENS TELLER LIMITED Active - Proposal to Strike off
10538181 COPPENWALL LIMITED Active

In using this service you agree to the Terms and Conditions

© 2025 First Report Ltd